Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03288350
Title mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors McGill University Health Center
Indications

stomach carcinoma

gastroesophageal junction adenocarcinoma

esophageal carcinoma

Therapies

Cisplatin + Docetaxel + Fluorouracil

Avelumab

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.